This week the drug olaparib (also known as Lynparza) was approved for use in Scotland for women with ovarian cancer by the Scottish Medicine’s Consortium. Scottish charity Worldwide Cancer Research funded work which kick-started the development of this drug over 20 years ago. Trials have shown ...

Employees at Editions Financial, a content marketing agency based in Edinburgh, have raised a fantastic £6,360.50 for Worldwide Cancer Research to allow the charity to continue funding and discovering pioneering research projects. Ten staff members across the organisation teamed up to take on Tr...

Sometimes discoveries from research into one disease hold promise for many others. This is the case of a new paper published today in the journal Scientific Reports. The team, led by researchers at the IDIBAPS Biomedical Research Institute (Barcelona, Spain) and supported by funding from Worldwide C...